Valuation: Psychemedics Corporation

Market Cap 9.79M 8.56M 7.87M 7.33M 13.91M 932M 14.12M 94.43M 36.71M 458M 36.75M 35.96M 1.58B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.34M 7.66M 7.14M 13.55M 908M 13.76M 92.01M 35.77M 447M 35.81M 35.04M 1.54B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 day+13.18%
1 month+13.18%
3 months+53.23%
6 months+56.60%
Current year+55.62%
1 month 2.2
Extreme 2.2
2.7
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
5.15
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 16/08/2023
Director of Finance/CFO 36 26/11/2023
Corporate Officer/Principal 40 20/09/2023
Director TitleAgeSince
Director/Board Member 64 15/03/2021
Director/Board Member 58 03/04/2022
Director/Board Member 64 11/08/2022
Date Insider Type Main position Quantity % Market Cap.
12/12/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
09/12/24Sell

Director

320,708 5.4408%
09/12/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
Change 5-day change 1-year change 3-year change Capi.($)
+13.18%-.--%+3.75%-44.79% 15.24M
+1.10%+6.65%+72.68%+472.96% 40B
+1.09%+5.71%+9.58%+37.36% 23.53B
+1.58%+4.06%-20.86%-40.58% 7.28B
+4.77%+13.19%+22.33%+117.22% 5.41B
-0.28%-2.58%+19.40%+46.08% 2.89B
-5.86%-3.31%-26.31%+1,042.30% 2B
+1.27%+6.99%+100.79%-3.93% 1.97B
-0.44%+7.04%+38.02%-22.20% 1.82B
+2.08%+0.70%+22.24%-3.56% 1.65B
Average +1.85%+4.39%+24.16%+160.09% 8.66B
Weighted average by Cap. +1.15%+6.85%+39.38%+257.63%

Financials

2023 2024
Net sales 22.1M 19.32M 17.75M 16.55M 31.39M 2.1B 31.86M 213M 82.85M 1.03B 82.95M 81.17M 3.56B 19.68M 17.21M 15.81M 14.74M 27.96M 1.87B 28.38M 190M 73.81M 921M 73.89M 72.3M 3.17B
Net income -4.15M -3.63M -3.34M -3.11M -5.9M -396M -5.99M -40.06M -15.58M -194M -15.59M -15.26M -670M -1.86M -1.63M -1.5M -1.39M -2.64M -177M -2.68M -17.95M -6.98M -87.1M -6.99M -6.84M -300M
Net Debt 334K 292K 268K 250K 474K 31.8M 482K 3.22M 1.25M 15.63M 1.25M 1.23M 53.87M -251K -219K -202K -188K -357K -23.9M -362K -2.42M -941K -11.75M -942K -922K -40.48M
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PMDI Stock